Yu-Ling Liang

Dr. Yu-Ling Liang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in Journal of Infection and Public Health
Verified
Journal Article
Open access
CLChih-Wei Lin
Chih-Wei Lin
YLYu-Ling Liang
Yu-Ling Liang
MCMing-Ta Chuang
Ming-Ta Chuang
CTChun Han Tseng
Chun Han Tseng
PTPei-Yin Tsai
Pei-Yin Tsai
MSMei-Tsz Su
Mei-Tsz Su
Paxlovid is an oral drug composed of nirmatrelvir and ritonavir that has been demonstrated to be effective in decreasing the risk of severe coronavirus disease 2019 (COVID-19). Here, we report the use of paxlovid in pregnant women with COVID-19. Pregnant women attending a tertiary referral hospital in Taiwan from 29 April to 30 July 2022 were enrolled in the study. We compared baseline characteristics, clinical manifestations, and adverse events between paxlovid-treated women and those without paxlovid use. Maternal and neonatal outcomes were analysed in women who delivered during the study period. A total of 30 paxlovid-treated pregnant women and 55 women without paxlovid use were included in the analysis. The mean duration of COVID-19-associated symptoms in the paxlovid-treated women was shorter than that in the control group (10.10 days versus 15.59 days, p = 0.04). No severe adverse events due to paxlovid use were observed. Dysgeusia and diarrhoea were the most common adverse effects. Thirteen paxlovid-treated and 28 untreated women delivered during the study period. More pregnant women in the paxlovid group who delivered during the study period underwent caesarean delivery compared to the group without antiviral treatment (10 of 13 [76.92%] versus 12 of 28 [42.86%], p = 0.042), and insignificantly more newborns were born small for gestational age in the paxlovid group compared to the control group (3 of 13 [23.08%] versus 1 of 28 [3.57%], p = 0.086). Our study showed that paxlovid was effective and safe for pregnant women during the Omicron wave of the COVID-19 pandemic. A higher proportion of caesarean delivery rates was observed among paxlovid-treated women. Long-term follow-up of pregnant women exposed to paxlovid and their offspring is needed.

Verified
Journal Article
Open access
PDF file
HTHsing-Fen Tsai
Hsing-Fen Tsai
CTChing-Fen Tseng
Ching-Fen Tseng
YLYu-Ling Liang
Yu-Ling Liang
PWPei-Ying Wu
Pei-Ying Wu
LHLan-Yin Huang
Lan-Yin Huang
KHKeng-fu Hsu
Keng-fu Hsu
Preeclampsia (PE) remains one of the leading causes of maternal and perinatal morbidity and mortality. However, the exact pathophysiology of PE is still unclear. The recent widely accepted notion that successful pregnancy relies on maternal immunological adaptation is of utmost importance. Moreover, salt-inducible kinase 3 (SIK3) is an AMP-activated protein kinase-related kinase, and it has reported a novel regulator of energy and inflammation, and its expression related with some diseases. To explore whether SIK3 expression correlated with PE, we analyzed SIK3 gene expression and its association with PE through GEO datasets. We identified that SIK3 was significantly downregulated in PE across four datasets (p < 0.05), suggesting that SIK3 participated in the pathogenesis of PE. We initially demonstrated the significant downregulation of SIK3 in trophoblast cells of PE. SIK3 downregulation was positively correlated with the increased number of CD204(+) cells in in vivo and in vitro experiments. The increased number of CD204(+) cells could inhibit the migration and invasion of trophoblast cells. We then clarified the potential mechanism of PE with SIK3 downregulation: M2 skewing was triggered by trophoblast cells derived via the CCL24/CCR3 axis, leading to an increase in CD204(+) cells, a decrease in phagocytosis, and the production of IL-10 at the maternal–fetal interface of the placenta with PE. IL-10 further contributed to a reduction in the migration and invasion of trophoblast cells. It also established a feedback loop wherein trophoblast cells increased CCL24 production to maintain M2 dominance in the placental environments of PE.

10 February 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
PCPo-Fan Chen
Po-Fan Chen
YLYu-Ling Liang
Yu-Ling Liang
Background: Uterine rupture in the third trimester is a rare but life-threatening obstetric emergency, with greater likelihood in pregnant patients with a history of uterine surgery. Case presentation: We present a unique case of uterine rupture at 30 weeks gestation in a patient with a recent surgical history of laparoscopic salpingectomy involving myometrial resection for interstitial ectopic pregnancy, who conceived five months after the procedure. This case provides valuable radiologic and surgical insights, highlighting the importance of imaging modalities in diagnosis and the potential risks associated with short interpregnancy intervals following prior uterine surgery. Conclusions: Early detection and prompt intervention are crucial for favorable maternal and fetal outcomes.